Cholecystectomy in Patients with Liver Cirrhosis

Gastroenterology Research and Practice
Jonas StrömbergGabriel Sandblom

Abstract

Background. The aim of this population-based study was to describe characteristics of patients with liver cirrhosis undergoing cholecystectomy and evaluate the risk for perioperative and postoperative complications during the 30-day postoperative period. Method. All laparoscopic and open cholecystectomy procedures registered between 2006 and 2011 in the Swedish Registry for Gallstone Surgery and ERCP (GallRiks) were included. Patients with liver cirrhosis were identified by linking data to the Swedish National Patient Registry (NPR). Results. Of 62,488 patients undergoing cholecystectomy, 77 (0.12%) had cirrhosis, of which 29 patients (37.7%) had decompensated cirrhosis. Patients with cirrhosis were older and had more often gallstone complications at the time for surgery. Postoperative complications were registered in 13 (16.9%) patients with liver cirrhosis and in 5,738 (9.2%) patients in the noncirrhotic group (P < 0.05). Univariable analysis showed that patients with liver cirrhosis are more likely to receive postoperative blood transfusion (OR = 4.4, CI 1.08-18.0, P < 0.05) and antibiotic treatment >1 day (OR = 2.3, CI 1.11-4.84, P < 0.05) than noncirrhotic patients. Conclusion. Patients with cirrhosis undergoing cholecyste...Continue Reading

References

Jul 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Christophe DuvouxDaniel Dhumeaux
Mar 23, 2005·Liver International : Official Journal of the International Association for the Study of the Liver·Annalisa BerzigottiMarco Zoli
May 3, 2005·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Michael Anthony Silva, Terence Wong
Jul 26, 2006·Journal of the American College of Surgeons·Chinnasamy PalaniveluRamakrishnan Parthasarthi
Oct 5, 2006·Current Opinion in Anaesthesiology·A Ziser, D J Plevak
Apr 30, 2008·Digestive Diseases and Sciences·David GulleySuthat Liangpunsakul
Nov 26, 2008·International Journal of Surgery·Saleh El-AwadiMohamed Farid
Feb 13, 2009·Expert Review of Gastroenterology & Hepatology·Jeanetta W Frye, Roman E Perri
Feb 21, 2009·Journal of the American College of Surgeons·Nicholas G CsikeszShimul A Shah
May 14, 2009·Scandinavian Journal of Gastroenterology·Steingerdur Anna GunnarsdottirEinar Björnsson
Mar 6, 2010·JSLS : Journal of the Society of Laparoendoscopic Surgeons·Abdul Razaque Shaikh, Ambreen Muneer
Feb 12, 2011·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Kevin Tri NguyenT Clark Gamblin
Jun 11, 2011·BMC Public Health·Jonas F LudvigssonPetra Otterblad Olausson
Jun 15, 2012·Journal of Gastroenterology and Hepatology·Amanda Nicoll
Oct 11, 2012·World Journal of Gastroenterology : WJG·Jan Lata
Dec 19, 2012·Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie·Michelle BuresiCarla S Coffin
Jan 16, 2013·JSLS : Journal of the Society of Laparoendoscopic Surgeons·Norman Oneil Machado
Feb 20, 2013·Journal of Hepatology·Martin BlachierFrançoise Roudot-Thoraval

❮ Previous
Next ❯

Citations

Jul 3, 2019·Journal of Gastroenterology and Hepatology·Kishan P PatelSomashekar G Krishna
Jun 24, 2020·Scientific Reports·Masashi YoshimotoNorihisa Takakura
Feb 28, 2017·International Journal of Hepatology·Wasana Ko-IamSunhawit Junrungsee
Dec 3, 2017·Best Practice & Research. Clinical Gastroenterology·Daniel Mønsted Shabanzadeh, Srdan Novovic

❮ Previous
Next ❯

Software Mentioned

GallRiks
SPSS Statistics

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.